The University of Queensland

Determine the therapeutic efficacy of CSL's drug candidate (2017–2018)

Grant type:

UniQuest Pty Ltd

Researchers:

• 

  Professor David Fairlie

  NHMRC Leadership Fellow and Group L
  

  Institute for Molecular Bioscience

Funded by:

UniQuest Pty Ltd